Pulmonary and Critical Care Medicine 2026

  • Continuing Education
3D lung imaging

-

Pulmonary and Critical Care Medicine 2026 offers a comprehensive update on state-of-the-art evaluation, diagnosis, treatment, and procedures for critically ill patients and patients with common, rare, and challenging pulmonary conditions.

  • Live Online

This program uses state-of-the-art streaming technology to present sessions online in real time. Participants can attend from any location, and can interact with faculty via live chat. 

 

Additionally, all sessions will be recorded and made available to participants for online viewing for 120 days after the end of the course.

 

All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 30 days in order to receive CME credit.)

This is the full tuition for physicians. A $100 early registration discount is available. 

 

For tuition for other medical professionals, please see the full table below. 

 

 

Early Registration Deadline:

Continuing Education Credits

Earn up to:
 

» 48.50 AMA PRA Category 1 Credits™

 

» 48.50 ABIM MOC points

 

» 48.50 ECME Credits®

 

» Commensurate credits through the Royal College of Physicians and Surgeons of Canada

 

View all

5 Days

This 5-day intensive course presents the most up-to-date, evidence-based approaches to pulmonary conditions and patients in need of critical care.

View schedule

On This Page

Overview

Comprehensive Updates for State-of-the-Art Care: Evaluation, Diagnosis, Treatment, Procedures, and Challenging Cases

Pulmonary and Critical Care Medicine is a live online course, using live streaming, electronic Q&A, and other remote learning technologies. The 2026 program will be highly interactive, providing opportunities throughout the program to pose questions online to nationally and internationally recognized leaders in their respective areas of pulmonary and critical care medicine.
This comprehensive course provides education and updates to optimize your care of patients with:

  • IPF
  • ARDS
  • Sarcoidosis
  • Lung transplantation
  • Bronchiectasis
  • Cystic fibrosis
  • Lung nodules
  • Lung cancer
  • Sepsis
  • Pleural disease
  • Pneumonia
  • Tuberculosis
  • Thromboembolism
  • Chronic cough
  • COPD
  • Asthma
  • Occupational and environmental lung disease
  • Interstitial lung disease
  • GERD
  • Neurologic issues in the ICU
  • Sleep-disordered breathing
  • Post-acute sequelae of COVID-19
  • Surgical emergencies
  • Atypical mycobacterial disease
  • Pulmonary hypertension
  • Cardiopulmonary disorders
  • Complications from cardiac arrest
  • Hypersensitivity pneumonitis
  • Acute respiratory failure

REASONS TO ATTEND IN 2026
All sessions are led by master clinicians who deliver information in inspiring and entertaining ways, and provide specific recommendations to incorporate the latest updates into your practice. Education covers:

  • The most current guidelines for treating sepsis
  • Evidence-based treatment of ARDS
  • State of the art in interventional pulmonology
  • High-flow oxygen therapy for respiratory failure
  • Updates on biologics in asthma and other lung disease
  • New concepts in the use of vasopressors in septic shock
  • New drugs and combinations in pulmonary hypertension
  • New evidence on sedation, analgesia, and early mobility in the ICU
  • Point-of-care pulmonary ultrasound in the intensive care unit
  • Lung microbiome: emerging implications for lung health
  • Emerging evidence for targeted temperature management
  • Evaluating occupational and environmental lung disease
  • Steroid-sparing agents for interstitial lung disease
  • Pulmonary embolus: the latest treatment strategies
  • State-of-the-art management of the critically ill patient
  • Guidance to conduct end-of-life discussions
  • Updates in pulmonary pathology
  • New treatment options in cystic fibrosis
  • Handling neurologic and surgical emergencies in the medical ICU
  • New approaches that improve outcomes for patients with unexplained chronic cough

Participants also have access to expanded question and answer sessions with faculty throughout the program, which promotes discussion of the complexity of real-world care.

On the afternoon of Friday, May, 1, participants can attend a special half-day program at no additional cost: Sleep Medicine for Pulmonologists. More information below.


In addition to being live streamed, all sessions will be recorded and placed in the online course library, enabling registrants to view them at their convenience. Recordings will be available for viewing for 120 days after the conclusion of the course. All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 30 days in order to receive CME credit.)
 

Developed and Offered By:

  • Massachusetts General Hospital logo

Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Massachusetts General Hospital.

Participant Types

 

  • Pulmonologists
  • Critical Care Physicians
  • Internists
  • Hospitalists
  • Nurse Practitioners
  • Physician Assistants
  • Residents and Fellows

Schedule

All schedule times are Eastern Daylight Time.

 

Please note that program changes / substitutions may be made without notice.

Day 1

Monday, April 27, 2026

Monday Morning Sessions

Moderator: Dr. Kathryn Hibbert

Welcome

Course Directors

7:45-8:00 am

Breaking News in Pulmonary Medicine

Dr. Eric Schmidt

8:00-8:40 am

Cystic Fibrosis: Understanding CFTR and New Treatment

Dr. Isabel Neuringer

8:40-9:20 am

Beyond Cystic Fibrosis: Diagnosis and Management of Non-CF Bronchiectasis

Dr. Christopher Richards

9:20-10:00 am

Break

Lung Transplantation 2026: Referral Patient Selection, Lung Allocation, and COVID

Dr. Brian Keller

10:10-10:50 am

Exercise and Cardiopulmonary Disorders: Indications and Interpretation

Dr. C. Corey Hardin

10:50-11:30 am

Q&A with Speakers

Drs. Isabel Neuringer, Christopher Richards, Brian Keller, and C. Corey Hardin

11:30 am-12:10 pm

Break

Monday Afternoon Sessions

Moderator: Dr. Angela Frank

Pulmonary Pathology: Interstitial Lung Disease

Dr. Lida Hariri

1:00-1:40 pm

Looking Deeper: Patterns and Insights from Chest Radiology

Dr. Amita Sharma

1:40-2:20 pm

Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD

Dr. Barry Shea

2:20-3:00 pm

Break

Hypersensitivity Pneumonitis: Pigeons, Farmers, and Hot Tubs, Oh My!

Dr. Sydney Montesi

3:10-3:50 pm

Treatment Challenges of Pulmonary Sarcoidosis

Dr. Robert Hallowell

3:50-4:30 pm

Diagnosis and Management of IPF: When, Why, and How to Use the Newest Drugs

Dr. Grace Peloquin

4:30-5:10 pm

Q&A with Speakers

Drs. Kathryn Hibbert, Angela Frank, Barry Shea, Robert Hallowell, Grace Peloquin, and Sydney Montesi

5:10-6:10 pm

Day 2

Tuesday, April 28, 2026

Tuesday Morning Sessions

Moderator: Dr. Kathryn Hibbert

Sedation, Analgesia, and Early Mobility: The State of the Art in 2026

Dr. Crystal North

8:00-8:40 am

Noninvasive Respiratory Support for Acute Respiratory Failure: Less May NOT Be Best

Carolyn La Vita, MHA, RRT

8:40-9:20 am

Novel Ventilator Modes: The Hype and Reality

Carolyn La Vita, MHA, RRT

9:20-10:00 am

Break

ARDS: State-of-the-Art Strategies to Protect the Lung

Dr. Jehan Alladina

10:10-10:50 am

After the ICU: Post-ICU Care Syndrome and Recovery

Dr. George Alba

10:50-11:30 am

Q&A with Speakers

Drs. Kathryn Hibbert, Angela Frank, Crystal North, George Alba, and Jehan Alladina, and Carolyn La Vita, MHA, RRT

11:30 am-12:10 pm

Break

Tuesday Afternoon Sessions

Moderator: Dr. Kathryn Hibbert

From Ancient Egypt to Balanced Crystalloids: Medicine's Attempts to Manage Sepsis

Dr. Eric Schmidt

1:00-1:40 pm

Fluid Responsiveness

Dr. David Ziehr

1:40-2:20 pm

Vasopressors in Septic Shock: Old Friends and New

Dr. Jason Griffith

2:20-3:00 pm

Break

Approach to Empiric Antibiotics in the ICU

Dr. Alyssa Letourneau

3:10-3:50 pm

Approach to the Immunocompromised Critically Ill Patient

Dr. Lisa Bebell

3:50-4:30 pm

Renal Replacement Therapy in the ICU: What and When to Start (or Not)

Dr. Andrew Allegretti

4:30-5:10 pm

Q&A with Speakers

Drs. Kathryn Hibbert, Lisa Bebell, Alyssa Letourneau, David Ziehr, Eric Schmidt, Jason Griffith, and Andrew Allegretti

5:10-6:10 pm

Day 3

Wednesday, April 29, 2026

Wednesday Morning Sessions

Moderator: Dr. Angela Frank

Common Neurologic Issues in the ICU

Dr. Sahar Zafar

8:00-8:40 am

TTM and Neuro-prognostication After Cardiac Arrest

Dr. David Greer

8:40-9:20 am

Surgical Emergencies in the Medical ICU

Dr. Noelle Saillant

9:20-10:00 am

Break

Updates in Management of Acute Pancreatitis

Dr. Casey Luckhurst

10:10-10:50 am

Advanced Cardiac Support in the ICU

Dr. David Dudzinski

10:50-11:30 am

Q&A with Speakers

Drs. Sahar Zafar, David Greer, Noelle Saillant, David Dudzinski, and Casey Luckhurst

11:30 am-12:10 pm

Break

Wednesday Afternoon Sessions

Moderator: Dr. Kathryn Hibbert

Breaking Updates in Critical Care

Dr. Kathryn Hibbert

1:00-1:40 pm

Management of the Acutely Hemorrhaging Patient

Dr. Angela Frank

1:40-2:20 pm

Point-of-Care Ultrasound in the Intensive Care Unit

Dr. Jonah Rubin

2:20-3:00 pm

Break

Pneumonia (Community and Hospital Acquired): Using the Newest Guidelines to Provide Evidence-Based Care

Dr. Joshua Metlay

3:10-3:50 pm

Prognosis and Uncertainty in the ICU

Dr. Emily Rubin

3:50-4:30 pm

Palliative Care in Advanced Lung Disease

Dr. Jaclyn Shameklis

4:30-5:10 pm

Q&A with Speakers

Drs. Kathryn Hibbert, Emily Rubin, Joshua Metlay, Jaclyn Shameklis, and Jonah Rubin

5:10-6:10 pm

Day 4

Thursday, April 30, 2026

Thursday Morning Sessions

Moderator: Dr. Angela Frank

Pleural Disease: 2026 Updates

Dr. Fayez Kheir

8:00-8:40 am

Interventional Pulmonology in 2026

Dr. Colleen Keyes

8:40-9:20 am

Interventional Bronchoscopy in COPD: Valves, Coils, and Beyond

Dr. Colleen Keyes

9:20-10:00 am

Break

Treatment of Non-Small Cell Lung Cancer: Traditional Chemotherapy, Targeted Therapy, and Immunotherapies

Dr. Kathryn Hibbert

10:10-10:50 am

COPD 2026

Dr. Walter O'Donnell

10:50-11:30 am

Q&A with Speakers

Drs. Angela Frank, Fayez Kheir, Colleen Keyes, and Walter O'Donnell

11:30 am-12:10 pm

Break

Thursday Afternoon Sessions

Moderator: Dr. Angela Frank

Aspergillus Lung Disease

Dr. Rod Rahimi

1:00-1:40 pm

Asthma: What's New in 2026

Dr. Miranda Theodore

1:40-2:20 pm

New Therapeutics in Lung Disease: The Age of Immunotherapy

Dr. Benjamin Medoff

2:20-3:00 pm

Break

A Strategic Approach to the Management of Pulmonary Nodules

Dr. Angela Frank

3:10-3:50 pm

Tuberculosis in 2026

Dr. Jodian Pinkney

3:50-4:30 pm

Nontuberculous Mycobacterial Disease: Navigating the Labyrinth

Dr. Rocio Hurtado

4:30-5:10 pm

Q&A with Speakers

Drs. Kathryn Hibbert, Benjamin Medoff, Rocio Hurtado, Angela Frank, Rod Rahimi, and Jodian Pinkney

5:10-6:10 pm

Day 5

Friday, May 1, 2026

Friday Morning Sessions

Moderator: Dr. Angela Frank

Thrombotic Mechanisms and Antithrombotic Agents: How Do the New Oral Agents Fit in 2026

Dr. Rachel Rosovsky

8:00-8:40 am

Pulmonary Embolism: An Update

Dr. Alison Witkin

8:40-9:20 am

Pulmonary Hypertension: Categorization and Evaluation

Dr. Josanna Rodriguez-Lopez

9:20-10:00 am

Break

Pulmonary Hypertension: Management

Dr. Alexandra Wong

10:10-10:50 am

Vasculitis and ANCA

Dr. Rachel Knipe

10:50-11:30 am

Q & A with Speakers

Drs. Alison Witkin, Josanna Rodriguez-Lopez, Alexandra Wong, Angela Frank, and Rachel Rosovsky

11:30 am-12:10 pm

Break

Afternoon Program: Sleep Medicine for Pulmonologists

Special half-day program moderated by Dr. James Mojica

1:00 - 5:00 pm

Obstructive Sleep Apnea

Dr. James Mojica

1:00-5:00 pm

Complex Sleep Apnea 2026

Dr. James Mojica

1:40-2:20 pm

Break

Sleep Diagnostics

Dr. Katherine Dudley

2:30-3:10 pm

Noninvasive Ventilation

Dr. Katherine Dudley

3:10-3:50 pm

Break

Q & A with Speakers

Drs. James Mojica and Katherine Dudley

4:00-5:00 pm

Optimized for Distance Learning

Live Stream

The 2026 program has been optimized for distance learning. 

In addition to being live streamed, all sessions and Q & A discussions will be recorded and made available to participants for online viewing for 120 days after the end of the course. This on-demand archive will permit those in different time zones or who have scheduling conflicts to avoid missing out on any sessions that are important to them. In addition, participants can review sessions to reinforce key learning points.

Q&A with Faculty

The 2026 program will be highly interactive, providing opportunities throughout the program to pose questions online to nationally and internationally recognized leaders in their respective areas of pulmonary and critical care medicine.

All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 30 days in order to receive CME credit.)

Sleep Medicine and Interventional Pulmonology

Sleep Medicine for Pulmonologists

May 1, 2026, 1:00-4:40 pm
Optional Half-Day Program
(No additional fees apply)
 

sleep mask for apnea

This sleep medicine program provides pulmonologists the opportunity to learn about recent advances in Sleep Medicine and how they impact clinical practice.

Offered on Friday afternoon, May 1, participants of Pulmonary and Critical Care Medicine 2026 can participate in this half-day program at no additional cost.

Highlights of this practical, interactive educational experience include:

  • Updates for diagnosis and management of sleep-disordered breathing
  • State-of-the-art management algorithms
  • New technologies vs. the “gold standard” polysomnogram
  • Reimbursement and telemedicine
  • Improved adherence to therapy

Participants will leave with specific recommendations to improve the clinical care of patients with sleep disorders.

Interventional Pulmonology

endoscope

This course covers advances in interventional pulmonology:

  • Diagnostic procedures
  • Therapeutic interventions
  • As an alternative to surgery

Learning Objectives

Upon completion of this course, participants will be able to:

  • Evaluate the pathophysiology of lung disease and critical illness, including key pathologic and radiologic features
  • Apply evidence from recent literature to clinical case management
  • Apply new clinical practice guidelines to improve patient outcomes
  • Utilize diagnostic and therapeutic tools offered by specialists outside of pulmonary and critical care medicine to optimally care for complicated patients
  • Review the latest evidence and best clinical practices for fluid resuscitation and vasopressor use

Faculty

Course Directors

 

George A. Alba, MD, Assistant Professor of Medicine

Jehan Alladina, MD, Assistant Professor of Medicine

Andrew Allegretti, MD, MSc, Assistant Professor of Medicine

Lisa Bebell, MD, MSc, Assistant Professor of Medicine

Katherine Dudley, MD, Instructor in Medicine

David M. Dudzinski, MD, Assistant Professor of Medicine

Angela J. Frank, MD, MPH, Instructor in Medicine

Jason Griffith, MD, PhD, Instructor in Medicine

Robert Hallowell, MD, Assistant Professor of Medicine

C. Corey Hardin, MD, PhD, Associate Professor of Medicine

Lida Hariri, MD, PhD, Associate Professor of Pathology

Kathryn A. Hibbert, MD, Assistant Professor of Medicine

Rocío M. Hurtado, MD, DTM&H, Assistant Professor of Medicine

David J. Kanarek, MBBCh, Associate Professor of Medicine

Brian Keller, MD, PhD, Assistant Professor of Medicine

Colleen M. Keyes, MD, Instructor in Medicine

Fayez Kheir, MD, MSc, Assistant Professor of Medicine

Rachel S. Knipe, MD, Assistant Professor of Medicine

Peggy Lai, MD, Associate Professor of Medicine

Alyssa R. Letourneau, MD, MPH, Assistant Professor of Medicine

Casey McBride Luckhurst. MD, Instructor in Surgery 

Benjamin D. Medoff, MD, Associate Professor of Medicine

Joshua P. Metlay, MD, PhD, Professor of Medicine

James E. Mojica, MD, FAASM, Instructor in Medicine

Sydney Montesi, MD, Associate Professor of Medicine 

Isabel Neuringer, MD, Assistant Professor of Medicine

Crystal M. North, MD, MPH, Assistant Professor of Medicine

Walter J. O'Donnell, MD, Assistant Professor of Medicine

Grace Peloquin, MD, Instructor in Medicine

Jodian A. Pinkney, MD, Instructor in Medicine

Rod Rahimi, MD, PhD, Assistant Professor of Medicine

Christopher Richards, MD, Instructor in Medicine

Josanna M. Rodriguez-Lopez, MD, Assistant Professor of Medicine

Rachel Rosovsky, MD, MPH, Associate Professor of Medicine

Emily Rubin, MD, Assistant Professor of Medicine

Jonah Rubin, MD, FCCP, Assistant Professor of Medicine

Noelle N. Saillant, MD, FACS, Associate Professor of Surgery

Kai Saukkonen, MD, Assistant Professor of Medicine

Eric Schmidt, MD, Associate Professor of Medicine

Jaime Laurel Schneider, MD, PhD, Instructor in Medicine

Jaclyn C. Shameklis, MD, Instructor in Medicine

Amita Sharma, MBBS, Associate Professor of Radiology

Barry S. Shea, MD, Assistant Professor of Medicine

Miranda Theodore, MD, Instructor in Medicine

Alison Witkin, MD, Assistant Professor of Medicine

Alexandra K. Wong, MD, Assistant Professor of Medicine

Sahar Zafar, MBBS, Associate Professor of Neurology

David Ziehr, MD, Instructor in Medicine

David Greer, MD, MA, Professor and Chair, Neurology, Boston University School of Medicine

Carolyn La Vita, MHA, RRT, Director, Respiratory Care Services, Massachusetts General Hospital

Course Fees

Fee Disclaimer

Registrations for Harvard Medical School CME programs are made via our secure online registration system. At the end of the registration process, a $10 non-refundable processing fee will be added to your registration. 

Upon receipt of your paid registration, an email confirmation will be sent to you. Be sure to include an email address that you check frequently. Your email address is used for critical information, including registration confirmation, evaluation, and certificate. 

Please review the cancellation policy.

Early Registration Deadline:

Role Course Fee

All registrants of Pulmonary and Critical Care Medicine 2026 will receive an electronic syllabus.

All sessions will be recorded as they are live streamed and placed in the online course video library, so that registrants can review them at their convenience. The video library will be available for 120 days after the conclusion of the course.

Accreditation

In support of improving patient care, Harvard Medical School is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Harvard Medical School designates this live activity for a maximum of 48.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 48.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For the purpose of recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center accept AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education). We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found on the European Union of Medical Specialties website.

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

Competencies

This course is designed to meet the following Institute of Medicine Core Competencies:

  • Employ Evidence-Based Practice
  • Work in Interdisciplinary Teams
  • Provide Patient-Centered Care

This course is designed to meet the following American Board of Medical Specialties (ABMS) / Accreditation Council for Graduate Medical Educational (ACGME) competencies:

  • Patient Care and Procedural Skills
  • Professionalism
  • Practice-Based Learning and Improvement
  • Medical Knowledge
  • Systems-Based Practice

Disclaimer & Disclosure

CME activities accredited by Harvard Medical School are offered solely for educational purposes and do not constitute any form of certification of competency. Practitioners should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind.

Note: AMA PRA Category 1 Credit™ is calculated based on submission of a preliminary agenda and may be subject to change.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education (ACCME), course planners, speakers, and content reviewers have been asked to disclose any relationships they have to companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Registration for courses managed by Harvard Medical School can only be completed through Harvard Medical School’s official registration portal: cmeregistration.hms.harvard.edu. Attendee registrations made through any other sites cannot be honored and will not be refunded. Please report any unauthorized websites or solicitations for registrations.

Program Topics